Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008850 |
---|---|
Receipt number | R000010390 |
Scientific Title | Randomized Phase II Study of BSC vs Cetuximab vs Irinotecan and Cetuximab in Patients with KRAS codon G13D mutant Metastatic Colorectal Cancer (G13 study) |
Date of disclosure of the study information | 2012/09/04 |
Last modified on | 2018/09/20 08:25:35 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/09/04 20:21:28 | ||
2 | Update | 2012/09/05 15:29:33 | Institute |
|
3 | Update | 2012/11/01 21:55:11 | Public title |
|
4 | Update | 2013/09/01 17:12:51 | Email Last name of contact person Last name of contact person Address |
|
5 | Update | 2015/07/02 21:49:50 | Recruitment status |
|
6 | Update | 2016/04/04 15:09:24 | Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address Name of primary person or sponsor Organization |
|
7 | Update | 2017/04/25 19:37:37 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results URL related to results and publications Results |
|
8 | Update | 2018/09/20 08:25:35 | Recruitment status |